AMPLYA

Modern methods of hemopurification: A revolutionary multitherapeutic treatment system designed to provide comprehensive support to critically ill patients. This system offers a wide range of therapeutic modalities, providing innovative options that open new horizons in treatment. These include all renal replacement modalities, innovative and specific sorbents, systemic or local-regional anticoagulation, and a universal set of bloodlines with pre-mounted hemofilters.

The Amplya system utilizes dual cassette "plug & play" technology, enabling fast and secure installation. All preparations and treatments are fully automated, simplifying personalized therapy management. The system features a touch screen interface, making operation easier and more intuitive. Additionally, a one-cassette technology has been implemented for all therapy modalities. Amplya enhances therapy management efficiency through advanced automation, optimal preparation time control, and integration of the widest range of therapeutic modalities into a single system.

It provides the most appropriate treatment and rapid intervention in conditions such as acute renal failure and multiorgan damage, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), sepsis, and autoimmune diseases. Amplya serves as a unified platform for multiple options, including CRRT, IRRT, PEX, CPFA, CO2 removal, and hemoperfusion.

Amplya facilitates the performance of a wide range of therapies and automates the management of complex treatments, reducing operational time and optimizing workflow.